- Women’s health and access to medical amenities are huge concerns in both developed and developing nations
- ETST’s wholly owned subsidiary, Earth Science Pharm Inc., is dedicated to research, with a goal of eradicating STIs
- The company has launched Hygee, its home detection kits for screening STIs
Earth Science Tech Inc. (OTCQB: ETST) is a Florida-based biotech company engaged in the production of premium-quality industrial hemp and cannabis/cannabidiol (CBD) products. ETST offers 100 percent organic and pure CBD oil, which is made using the supercritical CO2 liquid-extraction process.
An innovative product aimed at improving women’s ability to self-screen for STIs was recently released by one of ETST’s subsidiaries. This kit, known as the Hygee, has the potential to revolutionize the arena of sexual health, empowering women through its innovative design.
Earth Science Pharma Inc., one of three wholly owned subsidiaries of ETST, is an emerging medical-research company engaged in the development of low-cost medical devices, testing processes, noninvasive diagnostic tools and vaccines for sexually transmitted infections and/or diseases (http://ibn.fm/WJSKk). The company’s research and development efforts are being conducted under the guidance and leadership of CEO and Chief Science Officer Michel Aube.
Earth Science Pharma is specifically focusing on developing and bringing to market medical devices and vaccines that focus on improving the health of women. Women’s health and access to medical amenities are huge concerns in both developed and developing nations. The company recently launched MSN-2, its first medical device, as a part of its initiative to meet the medical needs of women.
MSN-2 is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ETST named this innovative kit Hygee, after the French goddess of health (http://ibn.fm/ZQ2Zf). Hygee is a home-detection kit used for screening of STIs from a self-obtained gynecological specimen (http://ibn.fm/YLKCE). The kit includes a modified pantyliner, which is used to collect a sample of human cells that is sent to be analyzed in a laboratory using proven technology.
With MSN-2, modified pantyliners are worn by women for a duration of four hours – long enough to collect the specimen needed for laboratory tests. This kit can be ordered online and provides women with the ease of conducting tests in comfortable environments. Testing for STIs is essential for pregnant women, who must be screened for chlamydia infections to reduce the risk of transmitting the disease to their babies during childbirth.
The first production run of Hygee is underway, and initial marketing will target North America, South America, Asia and Africa. The company will package Hygee in English, French, Portuguese, Spanish, Vietnamese and Arabic in order to reach a wide audience of consumers.
“No other existing method of collecting genital specimens from women is more convenient or more efficient than Hygee,” Aube added in a news release (http://ibn.fm/kdJJ1). “With roughly 130 million new chlamydia cases diagnosed yearly, according to the [World Health Organization], Hygee is dedicated to this area of women’s health.”
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
